Cannara Biotech, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.13 CAD
13.08 M CAD
107.20 M CAD
44.22 M
About Cannara Biotech, Inc.
Sector
Industry
CEO
Zohar Krivorot
Website
Headquarters
Montréal
Founded
2017
IPO date
Jan 14, 2019
Identifiers
3
ISIN CA13765U2002
Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. It operates under the Indoor Cannabis and Real Estate operating segments. The Indoor Cannabis segment is involved in cultivation, processing, and sale of dried cannabis and cannabis derivatives. The Real Estate segment focuses on the Farnham and Valleyfield building. The company was founded on October 19, 2017 and is headquartered in Montreal, Canada.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LOVE is 1.87 CAD — it has increased by 9.36% in the past 24 hours. Watch Cannara Biotech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange Cannara Biotech, Inc. stocks are traded under the ticker LOVE.
LOVE stock has risen by 11.31% compared to the previous week, the month change is a 7.47% rise, over the last year Cannara Biotech, Inc. has showed a 55.83% increase.
We've gathered analysts' opinions on Cannara Biotech, Inc. future price: according to them, LOVE price has a max estimate of 3.50 CAD and a min estimate of 3.50 CAD. Watch LOVE chart and read a more detailed Cannara Biotech, Inc. stock forecast: see what analysts think of Cannara Biotech, Inc. and suggest that you do with its stocks.
LOVE reached its all-time high on Jan 14, 2019 with the price of 3.45 CAD, and its all-time low was 0.61 CAD and was reached on Jul 15, 2024. View more price dynamics on LOVE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LOVE stock is 8.56% volatile and has beta coefficient of 0.89. Track Cannara Biotech, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cannara Biotech, Inc. there?
Today Cannara Biotech, Inc. has the market capitalization of 172.41 M, it has increased by 1.12% over the last week.
Yes, you can track Cannara Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
Cannara Biotech, Inc. is going to release the next earnings report on Apr 29, 2026. Keep track of upcoming events with our Earnings Calendar.
LOVE net income for the last quarter is 1.04 M CAD, while the quarter before that showed 3.31 M CAD of net income which accounts for −68.63% change. Track more Cannara Biotech, Inc. financial stats to get the full picture.
No, LOVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 452 employees. See our rating of the largest employees — is Cannara Biotech, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cannara Biotech, Inc. EBITDA is −1.16 M CAD, and current EBITDA margin is −1.19%. See more stats in Cannara Biotech, Inc. financial statements.
Like other stocks, LOVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cannara Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cannara Biotech, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cannara Biotech, Inc. stock shows the strong buy signal. See more of Cannara Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.